Giles Toogood


University of Oxford


Oxford, Cambridge and Adelaide, Australia

BM BChir M (Oxford)
MA (Oxford)
DM (Oxford)
FRCS (Royal College of Surgeons)

Current NHS Appointments Appointed 2006

 Professor in Hepatobiliary Surgery,  St James’s University Hospital and University of Leeds

Private Practice Hospitals

Spire Hospital Leeds

Nuffield Hospital Leeds

Positions of Office

President Elect Association of Upper Gastrointestinal Surgeons 2016 onwards

Chairman Great Britain and Ireland Hepatopancreatobiliary Association,  2009-2012

Chairman of Association of Upper Gastrointestinal Surgeons Committee of Education and Training, 2012-2016

Intercollegiate Specialty Boards Examiner for General Surgery, 2008 - to present

General Surgery Specialty Training Committee of Yorkshire, 1999 - to present

Royal College of Surgeons of England Assessor for Consultant Advisory Committees, 2005 - to present

European and African Hepatopancreatobiliary Association Education Committee, 2008 - to present

European Union of Medical Specialists Examiner, 2009 - to present

Chief External Examiner for University of Oxford 2014  to present


Clinical research is focused on outcome data of liver, gallbladder and transplantation patients, whilst laboratory work is aimed at novel treatments for people with colorectal liver cancer.

Over the past twelve years he has co supervised eight postgraduate fellows working towards PhDs and MDs, looking at the action of COX2 inhibitors (non steroidal anti inflammatory drugs) on colorectal liver cancer cells and producing a potential vaccination for colorectal liver cancer.


Author of over 160 publications and co applicant for several research grants. His publications can be accessed by typing in Toogood G at